Organic anion transporter 3
Details
- Name
- Organic anion transporter 3
- Synonyms
- hOAT3
- OAT3
- Organic anion/dicarboxylate exchanger
- Solute carrier family 22 member 8
- Gene Name
- SLC22A8
- UniProtKB Entry
- Q8TCC7Swiss-Prot
- Organism
- Humans
- NCBI Taxonomy ID
- 9606
- Amino acid sequence
>lcl|BSEQ0007005|Organic anion transporter 3 MTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCRPPHNASTGPW VLPMGPNGKPERCLRFVHPPNASLPNDTQRAMEPCLDGWVYNSTKDSIVTEWDLVCNSNK LKEMAQSIFMAGILIGGLVLGDLSDRFGRRPILTCSYLLLAASGSGAAFSPTFPIYMVFR FLCGFGISGITLSTVILNVEWVPTRMRAIMSTALGYCYTFGQFILPGLAYAIPQWRWLQL TVSIPFFVFFLSSWWTPESIRWLVLSGKSSKALKILRRVAVFNGKKEEGERLSLEELKLN LQKEISLAKAKYTASDLFRIPMLRRMTFCLSLAWFATGFAYYSLAMGVEEFGVNLYILQI IFGGVDVPAKFITILSLSYLGRHTTQAAALLLAGGAILALTFVPLDLQTVRTVLAVFGKG CLSSSFSCLFLYTSELYPTVIRQTGMGVSNLWTRVGSMVSPLVKITGEVQPFIPNIIYGI TALLGGSAALFLPETLNQPLPETIEDLENWSLRAKKPKQEPEVEKASQRIPLQPHGPGLG SS
- Number of residues
- 542
- Molecular Weight
- 59855.585
- Theoretical pI
- 9.05
- GO Classification
- Functionsorganic anion transmembrane transporter activity / prostaglandin transmembrane transporter activity / solute / xenobiotic transmembrane transporter activityProcessesmonoatomic ion transport / prostaglandin transport / transport across blood-brain barrierComponentsapical plasma membrane
- General Function
- Functions as an organic anion/dicarboxylate exchanger that couples organic anion uptake indirectly to the sodium gradient (PubMed:14586168, PubMed:15644426, PubMed:15846473, PubMed:16455804, PubMed:31553721). Transports organic anions such as estrone 3-sulfate (E1S) and urate in exchange for dicarboxylates such as glutarate or ketoglutarate (2-oxoglutarate) (PubMed:14586168, PubMed:15846473, PubMed:15864504, PubMed:22108572, PubMed:23832370). Plays an important role in the excretion of endogenous and exogenous organic anions, especially from the kidney and the brain (PubMed:11306713, PubMed:14586168, PubMed:15846473). E1S transport is pH- and chloride-dependent and may also involve E1S/cGMP exchange (PubMed:26377792). Responsible for the transport of prostaglandin E2 (PGE2) and prostaglandin F2(alpha) (PGF2(alpha)) in the basolateral side of the renal tubule (PubMed:11907186). Involved in the transport of neuroactive tryptophan metabolites kynurenate and xanthurenate (PubMed:22108572, PubMed:23832370). Functions as a biopterin transporters involved in the uptake and the secretion of coenzymes tetrahydrobiopterin (BH4), dihydrobiopterin (BH2) and sepiapterin to urine, thereby determining baseline levels of blood biopterins (PubMed:28534121). May be involved in the basolateral transport of steviol, a metabolite of the popular sugar substitute stevioside (PubMed:15644426). May participate in the detoxification/ renal excretion of drugs and xenobiotics, such as the histamine H(2)-receptor antagonists fexofenadine and cimetidine, the antibiotic benzylpenicillin (PCG), the anionic herbicide 2,4-dichloro-phenoxyacetate (2,4-D), the diagnostic agent p-aminohippurate (PAH), the antiviral acyclovir (ACV), and the mycotoxin ochratoxin (OTA), by transporting these exogenous organic anions across the cell membrane in exchange for dicarboxylates such as 2-oxoglutarate (PubMed:11669456, PubMed:15846473, PubMed:16455804). Contributes to the renal uptake of potent uremic toxins (indoxyl sulfate (IS), indole acetate (IA), hippurate/N-benzoylglycine (HA) and 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF)), pravastatin, PCG, E1S and dehydroepiandrosterone sulfate (DHEAS), and is partly involved in the renal uptake of temocaprilat (an angiotensin-converting enzyme (ACE) inhibitor) (PubMed:14675047). May contribute to the release of cortisol in the adrenals (PubMed:15864504). Involved in one of the detoxification systems on the choroid plexus (CP), removes substrates such as E1S or taurocholate (TC), PCG, 2,4-D and PAH, from the cerebrospinal fluid (CSF) to the blood for eventual excretion in urine and bile (By similarity). Also contributes to the uptake of several other organic compounds such as the prostanoids prostaglandin E(2) and prostaglandin F(2-alpha), L-carnitine, and the therapeutic drugs allopurinol, 6-mercaptopurine (6-MP) and 5-fluorouracil (5-FU) (By similarity). Mediates the transport of PAH, PCG, and the statins pravastatin and pitavastatin, from the cerebrum into the blood circulation across the blood-brain barrier (BBB). In summary, plays a role in the efflux of drugs and xenobiotics, helping reduce their undesired toxicological effects on the body (By similarity)
- Specific Function
- Organic anion transmembrane transporter activity
- Pfam Domain Function
- Sugar_tr (PF00083)
- Signal Regions
- Not Available
- Transmembrane Regions
- 10-30 124-144 155-175 177-197 213-233 237-257 328-348 355-375 387-407 412-432 472-492
- Cellular Location
- Basolateral cell membrane
- Gene sequence
>lcl|BSEQ0019450|Solute carrier family 22 member 8 (SLC22A8) ATGACCTTCTCGGAGATCCTGGACCGTGTGGGAAGCATGGGCCATTTCCAGTTCCTGCAT GTAGCCATACTGGGCCTCCCGATCCTCAACATGGCCAACCACAACCTGCTGCAGATCTTC ACAGCCGCCACCCCTGTCCACCACTGTCGCCCGCCCCACAATGCCTCCACAGGGCCTTGG GTGCTCCCCATGGGCCCAAATGGGAAGCCTGAGAGGTGCCTCCGTTTTGTACATCCGCCC AATGCCAGCCTGCCCAATGACACCCAGAGGGCCATGGAGCCATGCCTGGATGGCTGGGTC TACAACAGCACCAAGGACTCCATTGTGACAGAGTGGGACTTGGTGTGCAACTCCAACAAA CTGAAGGAGATGGCCCAGTCTATCTTCATGGCAGGTATACTGATTGGAGGGCTCGTGCTT GGAGACCTGTCTGACAGGTTTGGCCGCAGGCCCATCCTGACCTGCAGCTACCTGCTGCTG GCAGCCAGCGGCTCCGGTGCAGCCTTCAGCCCCACCTTCCCCATCTACATGGTCTTCCGC TTCCTGTGTGGCTTTGGCATCTCAGGCATTACCCTGAGCACCGTCATCTTGAATGTGGAA TGGGTGCCTACCCGGATGCGGGCCATCATGTCGACAGCACTCGGGTACTGCTACACCTTT GGCCAGTTCATTCTGCCCGGCCTGGCCTACGCCATCCCCCAGTGGCGTTGGCTGCAGTTA ACTGTGTCCATTCCCTTCTTCGTCTTCTTCCTATCATCCTGGTGGACACCAGAGTCCATA CGCTGGTTGGTCTTGTCTGGAAAGTCCTCGAAGGCCCTGAAGATACTCCGGCGGGTGGCT GTCTTCAATGGCAAGAAGGAAGAGGGAGAAAGGCTCAGCTTGGAGGAGCTCAAACTCAAC CTGCAGAAGGAGATCTCCTTGGCCAAGGCCAAGTACACCGCAAGTGACCTGTTCCGGATA CCCATGCTGCGCCGCATGACCTTCTGTCTTTCCCTGGCCTGGTTTGCTACCGGTTTTGCC TACTATAGTTTGGCTATGGGTGTGGAAGAATTTGGAGTCAACCTCTACATCCTCCAGATC ATCTTTGGTGGGGTCGATGTCCCAGCCAAGTTCATCACCATCCTCTCCTTAAGCTACCTG GGCCGGCATACCACTCAGGCCGCTGCCCTGCTCCTGGCAGGAGGGGCCATCTTGGCTCTC ACCTTTGTGCCCTTGGACTTGCAGACCGTGAGGACAGTATTGGCTGTGTTTGGGAAGGGA TGCCTATCCAGCTCCTTCAGCTGCCTCTTCCTCTACACAAGTGAATTATACCCCACAGTC ATCAGGCAAACAGGTATGGGCGTAAGTAACCTGTGGACCCGCGTGGGAAGCATGGTGTCC CCGCTGGTGAAAATCACGGGTGAGGTACAGCCCTTCATCCCCAATATCATCTACGGGATC ACCGCCCTCCTCGGGGGCAGTGCTGCCCTCTTCCTGCCTGAGACCCTGAATCAGCCCTTG CCAGAGACTATCGAAGACCTGGAAAACTGGTCCCTGCGGGCAAAGAAGCCAAAGCAGGAG CCAGAGGTGGAAAAGGCCTCCCAGAGGATCCCTCTACAGCCTCACGGACCAGGCCTGGGC TCCAGCTGA
- Chromosome Location
- 11
- Locus
- 11q12.3
- External Identifiers
Resource Link UniProtKB ID Q8TCC7 UniProtKB Entry Name S22A8_HUMAN GenBank Protein ID 4378059 GenBank Gene ID AF097491 GeneCard ID SLC22A8 HGNC ID HGNC:10972 KEGG ID hsa:9376 IUPHAR/Guide To Pharmacology ID 1027 NCBI Gene ID 9376 - General References
- Race JE, Grassl SM, Williams WJ, Holtzman EJ: Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun. 1999 Feb 16;255(2):508-14. [Article]
- Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article]
- Taylor TD, Noguchi H, Totoki Y, Toyoda A, Kuroki Y, Dewar K, Lloyd C, Itoh T, Takeda T, Kim DW, She X, Barlow KF, Bloom T, Bruford E, Chang JL, Cuomo CA, Eichler E, FitzGerald MG, Jaffe DB, LaButti K, Nicol R, Park HS, Seaman C, Sougnez C, Yang X, Zimmer AR, Zody MC, Birren BW, Nusbaum C, Fujiyama A, Hattori M, Rogers J, Lander ES, Sakaki Y: Human chromosome 11 DNA sequence and analysis including novel gene identification. Nature. 2006 Mar 23;440(7083):497-500. [Article]
- Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article]
- Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa O, Inui K: Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol. 2002 Apr;13(4):866-74. [Article]
- Bakhiya A, Bahn A, Burckhardt G, Wolff N: Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux. Cell Physiol Biochem. 2003;13(5):249-56. [Article]
- Srimaroeng C, Chatsudthipong V, Aslamkhan AG, Pritchard JB: Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8). J Pharmacol Exp Ther. 2005 May;313(2):621-8. Epub 2005 Jan 11. [Article]
- Tahara H, Shono M, Kusuhara H, Kinoshita H, Fuse E, Takadate A, Otagiri M, Sugiyama Y: Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney. Pharm Res. 2005 Apr;22(4):647-60. Epub 2005 Apr 7. [Article]
- Tahara H, Kusuhara H, Maeda K, Koepsell H, Fuse E, Sugiyama Y: Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid. Drug Metab Dispos. 2006 May;34(5):743-7. doi: 10.1124/dmd.105.008375. Epub 2006 Feb 2. [Article]
- Nishizato Y, Ieiri I, Suzuki H, Kimura M, Kawabata K, Hirota T, Takane H, Irie S, Kusuhara H, Urasaki Y, Urae A, Higuchi S, Otsubo K, Sugiyama Y: Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther. 2003 Jun;73(6):554-65. [Article]
- Erdman AR, Mangravite LM, Urban TJ, Lagpacan LL, Castro RA, de la Cruz M, Chan W, Huang CC, Johns SJ, Kawamoto M, Stryke D, Taylor TR, Carlson EJ, Ferrin TE, Brett CM, Burchard EG, Giacomini KM: The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics. Am J Physiol Renal Physiol. 2006 Apr;290(4):F905-12. Epub 2005 Nov 15. [Article]
Associated Data
- Bio-Entities
Bio-Entity Type Organic anion transporter 3 (Humans) protein primary- Drug Relations
Drug Drug group Pharmacological action? Type Actions Details Probenecid approved, investigational yes target inhibitor Details Testosterone approved, investigational unknown transporter inducer Details Taurocholic acid approved, experimental unknown transporter substrateinhibitor Details Salicylic acid approved, investigational, vet_approved unknown transporter inhibitor Details Quinidine approved, investigational unknown transporter inhibitor Details Probenecid approved, investigational unknown transporter inhibitor Details Benzylpenicillin approved, vet_approved unknown transporter substrateinhibitor Details Ouabain approved unknown transporter inhibitor Details Indomethacin approved, investigational unknown transporter inhibitor Details Ibuprofen approved unknown transporter inhibitor Details Guanidine approved unknown transporter inhibitor Details Glutaric Acid experimental unknown transporter substrateinhibitor Details Furosemide approved, vet_approved unknown transporter inhibitor Details Diclofenac approved, vet_approved unknown transporter inhibitor Details Cholic Acid approved unknown transporter substrateinhibitor Details Bumetanide approved unknown transporter inhibitor Details Cilastatin approved, investigational unknown transporter inhibitor Details Piroxicam approved, investigational unknown transporter inhibitor Details Aminohippuric acid approved, investigational unknown transporter substrateinhibitor Details Caprylic acid investigational unknown transporter inhibitor Details Cimetidine approved, investigational unknown transporter substrateinhibitor Details Aspartame investigational, nutraceutical unknown transporter inhibitor Details Tetracycline approved, vet_approved, withdrawn unknown transporter substrateinhibitor Details Oxytetracycline approved, investigational, vet_approved unknown transporter substrate Details Ganciclovir approved, investigational unknown transporter inhibitor Details Acyclovir approved unknown transporter substrateinhibitor Details Dinoprostone approved unknown transporter substrateinhibitor Details Cefalotin approved, investigational, vet_approved unknown transporter inhibitor Details Cefoperazone approved, investigational unknown transporter inhibitor Details Cefazolin approved unknown transporter inhibitor Details Cefamandole approved, experimental unknown transporter inhibitor Details Cefadroxil approved, vet_approved, withdrawn unknown transporter inhibitor Details Ceftriaxone approved unknown transporter inhibitor Details Cefotaxime approved unknown transporter inhibitor Details Phenylbutazone approved, vet_approved unknown transporter inhibitor Details Ketoprofen approved, vet_approved unknown transporter inhibitor Details Pravastatin approved no transporter substrateinhibitor Details Famotidine approved no transporter substrateinhibitor Details Liothyronine approved, vet_approved unknown transporter inhibitor Details Methotrexate approved unknown transporter substrateinhibitor Details Conjugated estrogens approved unknown transporter substrateinhibitor Details Tenoxicam approved unknown transporter inhibitor Details Enalapril approved, vet_approved unknown transporter inhibitor Details trans-2-hydroxycinnamic acid experimental unknown transporter inhibitor Details Cephalexin approved, investigational, vet_approved unknown transporter inhibitor Details Valproic acid approved, investigational unknown transporter substrateinhibitor Details Melatonin approved, nutraceutical, vet_approved unknown transporter inhibitor Details Benzoic acid approved, investigational unknown transporter inhibitor Details Mercaptopurine approved unknown transporter substrateinhibitor Details Novobiocin approved, investigational, vet_approved, withdrawn unknown transporter inhibitor Details Pantoprazole approved unknown transporter inhibitor Details Succinic acid approved, nutraceutical unknown transporter substrate Details Cyclic adenosine monophosphate experimental unknown transporter substrate Details Valaciclovir approved, investigational unknown transporter substrate Details Oxalic Acid experimental unknown transporter substrate Details Ranitidine approved, withdrawn unknown transporter substrate Details Levocarnitine approved, investigational unknown transporter substrate Details Allopurinol approved unknown transporter substrate Details Oseltamivir approved unknown transporter substrate Details Liotrix approved unknown transporter inhibitor Details Cefacetrile experimental, vet_approved unknown transporter substrateinhibitor Details Methyltestosterone approved unknown transporter inducer Details Zidovudine approved unknown transporter substrateinhibitor Details Uric acid investigational unknown transporter Details Estradiol approved, investigational, vet_approved unknown transporter substrate Details Prasterone sulfate investigational unknown transporter Details Dinoprost tromethamine approved, vet_approved unknown transporter Details Degraded Cephaloridine experimental unknown transporter Details Tetraethylammonium experimental, investigational unknown transporter Details Saxagliptin approved unknown transporter substrate Details Dabrafenib approved, investigational no transporter inhibitor Details Tenofovir disoproxil approved, investigational unknown transporter substrate Details Cefotaxime approved unknown target Details Ceftriaxone approved unknown target Details Benzylpenicillin approved, vet_approved unknown target substrateinhibitor Details Eluxadoline approved, investigational unknown transporter substrate Details Avibactam approved no transporter substrate Details Topiroxostat experimental unknown transporter inhibitor Details Ataluren approved, investigational no enzyme inhibitor Details Enasidenib approved, investigational unknown transporter inhibitor Details Letermovir approved, investigational unknown transporter inhibitor Details Dolutegravir approved no transporter inhibitor Details Rucaparib approved, investigational no transporter inhibitor Details Baricitinib approved, investigational unknown transporter substrateinhibitor Details Testosterone cypionate approved unknown transporter inducer Details Testosterone enanthate approved unknown transporter inducer Details Testosterone undecanoate approved, investigational unknown transporter inducer Details Estradiol acetate approved, investigational, vet_approved unknown transporter Details Estradiol benzoate approved, investigational, vet_approved unknown transporter Details Estradiol cypionate approved, investigational, vet_approved unknown transporter Details Estradiol dienanthate approved, investigational, vet_approved unknown transporter Details Estradiol valerate approved, investigational, vet_approved unknown transporter Details Apalutamide approved, investigational no transporter inhibitor Details Estrone approved unknown transporter substrate Details Cefaclor approved unknown transporter substrateinhibitor Details Cefdinir approved unknown transporter substrate Details Cefotiam approved, investigational unknown transporter substrateinhibitor Details Ceftibuten approved, investigational unknown transporter substrateinhibitor Details Ceftizoxime approved, withdrawn unknown transporter substrateinhibitor Details Cefaloridine experimental, withdrawn unknown transporter substrateinhibitor Details Hydrocortisone approved, vet_approved unknown transporter substrate Details Edaravone approved, investigational no transporter substrate Details Fexofenadine approved, investigational unknown transporter substrate Details Leucovorin approved unknown transporter substrateinhibitor Details Quinapril approved, investigational unknown transporter substrate Details Rosuvastatin approved unknown transporter substrateinhibitor Details Sitagliptin approved, investigational unknown transporter substrate Details Hydrocortisone aceponate experimental, vet_approved unknown transporter Details Hydrocortisone acetate approved, vet_approved unknown transporter Details Hydrocortisone butyrate approved, vet_approved unknown transporter Details Hydrocortisone cypionate approved, investigational, vet_approved unknown transporter Details Hydrocortisone phosphate approved, vet_approved unknown transporter Details Hydrocortisone probutate approved, vet_approved unknown transporter Details Hydrocortisone valerate approved, vet_approved unknown transporter Details Ivosidenib approved, investigational unknown transporter inhibitor Details Lenvatinib approved, investigational unknown transporter inhibitor Details Piperacillin approved unknown transporter substrate Details Tazobactam approved unknown transporter substrateinhibitor Details Rifampin approved unknown transporter inhibitor Details Cabotegravir approved, investigational unknown transporter inhibitor Details Dexibuprofen approved, investigational unknown transporter Details Pradigastat investigational unknown transporter inhibitor Details Pemetrexed approved, investigational no transporter substrate Details Lansoprazole approved, investigational unknown transporter inhibitor Details Doripenem approved, investigational no transporter substrate Details Acetylsalicylic acid approved, vet_approved unknown transporter inhibitor Details Esomeprazole approved, investigational unknown transporter inhibitor Details Tenofovir alafenamide approved no transporter substrate Details Tenofovir experimental, investigational no transporter substrate Details Naproxen approved, vet_approved unknown transporter Details Relebactam approved, investigational unknown transporter substrate Details Pretomanid approved unknown transporter inhibitor Details Latanoprost approved, investigational unknown transporter inhibitor Details Hydrochlorothiazide approved, vet_approved unknown transporter substrate Details Gemfibrozil approved unknown target inhibitor Details Dronedarone approved unknown transporter inhibitor Details Budesonide approved unknown transporter substrate Details Dexamethasone approved, investigational, vet_approved unknown transporter substrate Details Tafamidis approved, investigational unknown transporter inhibitor Details Rimegepant approved, investigational unknown transporter inhibitor Details Favipiravir approved, investigational unknown transporter inhibitor Details Osilodrostat approved, investigational unknown transporter inhibitor Details Medrysone approved unknown transporter substrate Details Hydroflumethiazide approved, investigational, withdrawn unknown transporter substrateinhibitor Details Polythiazide approved unknown transporter substrate Details Prednisolone phosphate approved, vet_approved unknown transporter substrate Details Empagliflozin approved unknown transporter substrate Details Artesunate approved, investigational unknown transporter inhibitor Details Betamethasone phosphate approved, vet_approved unknown transporter substrate Details Dexamethasone acetate approved, investigational, vet_approved unknown transporter substrate Details Cortisone acetate approved, investigational unknown transporter substrate Details Linezolid approved, investigational no transporter inhibitor Details Cloxacillin approved, investigational, vet_approved no transporter substrateinhibitor Details Brincidofovir approved, investigational no transporter inhibitor Details Fexinidazole approved, investigational unknown transporter inhibitor Details Abrocitinib approved, investigational unknown transporter substrate Details Roxadustat approved, investigational unknown transporter substrate Details Linzagolix approved no transporter substrateinhibitor Details Olutasidenib approved, investigational no transporter inhibitor Details Daprodustat approved, investigational no transporter substrate Details Olsalazine approved unknown transporter upregulator Details Sparsentan approved, investigational unknown transporter inhibitor Details Tezacaftor approved, investigational no transporter inhibitor Details Vadadustat approved, investigational unknown transporter substrateinhibitor Details Encorafenib approved, investigational no transporter inhibitor Details Capivasertib approved, investigational no transporter inhibitor Details Avatrombopag approved, investigational no transporter inhibitor Details Resmetirom approved, investigational unknown transporter inhibitor Details Cefixime approved, investigational unknown transporter substrate Details Deuruxolitinib investigational unknown transporter inhibitor Details Seladelpar approved, investigational unknown transporter substrate Details Iron (III) oxide adipate investigational yes target inhibitor Details Glutaric Acid experimental yes target inhibitor Details Aminohippuric acid approved, investigational yes target inhibitor Details Fluorescein approved yes target inhibitor Details